Zobrazeno 1 - 10
of 14
pro vyhledávání: '"M. A. Shuklina"'
Autor:
L. M. Tsybalova, L. A. Stepanova, A. V. Korotkov, M. A. Shuklina, M. V. Zaitseva, V. I. Grishchenko, R. Yu. Kotlyarov
Publikováno v:
Инфекция и иммунитет, Vol 9, Iss 3-4, Pp 485-494 (2019)
Generating cross-reactive vaccines aimed at targeting all human influenza A virus subtypes is among high priority tasks in contemporary vaccinology. Such vaccines will be primarily demanded during pre-pandemic period as well as used to prime some pop
Externí odkaz:
https://doaj.org/article/772c70c0aa8746b58a1050dd91f199af
Autor:
L. M. Tsybalova, L. A. Stepanova, M. A. Shuklina, S. V. Petrov, A. A. Kovaleva, M. V. Potapchuk, A. A. Shaldzhan, Y. A. Zabrodskaya, V. V. Egorov
Publikováno v:
Вопросы вирусологии, Vol 63, Iss 2, Pp 68-76 (2018)
One of the main problems in the area of influenza prophylaxis and pandemic prevention is the development of cross-reactive vaccines, i.e. vaccines directed against all subtypes of human influenza viruses. Such vaccines are being developed in many cou
Externí odkaz:
https://doaj.org/article/f6fb9bc1281f466cadf44e1413440801
Autor:
L. A. Stepanova, M. A. Shuklina, E. A. Blokhina, R. Y. Kotlyarov, A. A. Kovaleva, N. V. Ravin, L. M. Tsybalova
Publikováno v:
Журнал инфектологии, Vol 9, Iss 4, Pp 43-52 (2018)
The influenza virus is the most unique in the level of variability of antigenic and biological properties. Because of constant mutations into genes coding surface viral proteins, in modern vaccines it is necessary to replace 1–2 virus components an
Externí odkaz:
https://doaj.org/article/258e1deac94147d29cfee8ff5115cad8
Autor:
L. M. Tsybalova, L. A. Stepanova, R. Yu. Kotlyarov, E. A. Blokhina, M. A. Shuklina, E. S. Mardanova, A. V. Korotkov, M. V. Potapchuk, N. V. Ravin
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 16, Iss 3, Pp 65-70 (2017)
The development of universal influenza vaccine - a vaccine directed to all subtypes of human influenza A viruses - is the really actual problem task. This paper presents the comparative characteristic of the specific activity of various recombinant p
Externí odkaz:
https://doaj.org/article/8d1cf5003b634a79bd2df95b18cf0ba7
Autor:
M. A. Shuklina, L. A. Stepanova, I. G. Vidyaeva, A. V. Korotkov, E. I. Eletskaya, L. M. Tsybalova
Publikováno v:
Инфекция и иммунитет, Vol 8, Iss 4 (2018)
Externí odkaz:
https://doaj.org/article/508fabca90ba4936a6017b043b1d3291
Autor:
M. A Shuklina, L. A Stepanova, A. A. Kovaleva, A. V. Korotkov, A. A. Shaldzhyan, M. V. Zaitceva, E. I. Eletskaya, L. M. Tsybalova
Publikováno v:
Medicinskaâ Immunologiâ, Vol 22, Iss 2, Pp 357-370 (2020)
Development of vaccines with a broad-spectrum of protection is one of the priorities in the programs of influenza prevention. Recently, the conserved fragments of influenza virus proteins (M1, M2, NP, the second subunit of the hemagglutinin HA2) prov
Autor:
M. A. Shuklina, L. A. Stepanova, Roman Y. Kotlyarov, A. A. Kovaleva, E. A. Blokhina, Nikolai V. Ravin, L. M. Tsybalova
Publikováno v:
Žurnal Infektologii, Vol 9, Iss 4, Pp 43-52 (2018)
The influenza virus is the most unique in the level of variability of antigenic and biological properties. Because of constant mutations into genes coding surface viral proteins, in modern vaccines it is necessary to replace 1–2 virus components an
Autor:
I. G. Vidyaeva, E. I. Eletskaya, M. A. Shuklina, L. M. Tsybalova, L. A. Stepanova, A. V. Korotkov
Publikováno v:
Infekciâ i Immunitet, Vol 8, Iss 4 (2018)
Autor:
M L, Shuklina
Publikováno v:
Voprosy okhrany materinstva i detstva. 13(6)
Publikováno v:
Voprosy okhrany materinstva i detstva. 13(7)